Pages
Products
HIF1A adenovirus

HIF1A adenovirus

Cat.No. :  AD00346Z

Titer: ≥1x10^10 IFU/mL / ≥1x10^11 IFU/mL / ≥1x10^11 VP/mL / ≥1x10^12 VP/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Adenovirus Particle Information

Quality Control

Gene Informationn

Cat. No. AD00346Z
Description Human Adenovirus Type5 (dE1/E3) expressing Hypoxia-inducible Factor 1, Alpha Subunit (basic Helix-loop-helix Transcription Factor) (HIF1A) under a CMV promoter. No fusion tag, pre-made adenovirus, ready to ship and ready to use format.
Target Gene HIF1A
Product Type Adenoviral particle
Insert HIF1A
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 250 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Gene Name
Gene Symbol
Gene ID
mRNA Refseq
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

The hypoxia-inducible factor 1-α (HIF1A) gene encodes a key transcription factor that plays a central role in the cellular response to low oxygen levels (hypoxia). HIF1A is a subunit of the heterodimeric HIF1 complex, which regulates the expression of numerous genes involved in angiogenesis, erythropoiesis, glucose metabolism, and cell survival. Under normoxic conditions, HIF1A is rapidly degraded by the proteasome due to hydroxylation by prolyl hydroxylases (PHDs) and subsequent recognition by the von Hippel-Lindau (VHL) tumor suppressor protein. However, under hypoxic conditions, hydroxylation is inhibited, leading to HIF1A stabilization, nuclear translocation, and binding to hypoxia response elements (HREs) in target genes. Dysregulation of HIF1A is associated with a variety of diseases, including cancer, ischemic disorders, and chronic inflammation, making it a key therapeutic target.

The HIF1A adenovirus is a recombinant viral vector designed to deliver the HIF1A gene to target cells for research or therapeutic purposes. Adenoviral vectors are widely used due to their high transduction efficiency, ability to infect both dividing and non-dividing cells, and relatively large cargo capacity. HIF1A adenoviruses are crucial for studying HIF1A-mediated pathways, such as angiogenesis in ischemic tissue repair and metabolic reprogramming in cancer. Furthermore, HIF1A adenoviruses have potential therapeutic applications, including promoting angiogenesis in ischemic diseases and enhancing stem cell survival in regenerative medicine.

Bone is a highly dynamic tissue that is constantly undergoing formation and resorption. Through RNA sequencing analysis, the researchers found that specific genes involved in regulating osteoblast differentiation are regulated by HIF-1α and HIF-2α, but in slightly different ways. Increased HIF-1α expression inhibits osteoblast differentiation by inhibiting RUNX2 function through upregulating Twist2 gene expression, which has been confirmed in Hif1a conditional knockout (KO) mice. Ectopic expression of HIF-1α by adenoviral transduction increased RANKL expression and activity, while knockdown of Hif1a expression by siRNA or osteoblast-specific depletion of Hif1a in conditional KO mice had no significant effect on osteoblast-mediated osteoclast activation. This unexpected result was elucidated by the upregulation of HIF-2α after Hif1a overexpression, which demonstrated that Hif2a is a transcriptional target of HIF-1α in regulating RANKL expression, and was verified by experiments in which HIF-2α was knocked down after HIF-1α overexpression. These findings suggest that HIF-1α plays an important role in regulating bone homeostasis by controlling osteoblast differentiation and affects osteoclast formation by regulating RANKL secretion (mediated by HIF-2α).

Ectopic expression of HIF-1α by adenoviral transduction system showed that the differentiation of primary calvarial preosteoblasts was inhibited. HIF-1α overexpression reduced the expression of osteoblast marker genes Ocn and Runx2 (Figure 1a), and ALP and ARS staining showed that mineralization and calcification nodule formation were inhibited (Figure 1b). BMP-2-induced regeneration of calvarial bone defect model confirmed the inhibitory effect of HIF-1α on osteoblast differentiation (Figure 1c). Implantation of Ad-Hif1a in the calvarial defect area significantly delayed BMP-2-induced bone regeneration (Figure 1c). Knockdown of Hif1a by RNAi increased the expression of osteoblast marker genes (Figure 1d), mineralization and calcification nodule formation (Figure 1e). In addition, HIF-1α overexpression significantly reduced RUNX2 activity (Figure 2f). In the current RNA sequencing data (Figure 1f), Twist2 is usually upregulated by HIF-1α and HIF-2α overexpression. Similar to the effects of HIF-2α, HIF-1α overexpression upregulated Twist2 but not Twist1 (Figure 1g). The regulatory cis-element of the Twist2 promoter contains a putative HIF-1α binding sequence 5′-(A/G)CGTG-3′ (Figure 1h). In addition, siRNA-mediated silencing of Hif1a in primary cultured calvarial osteoblasts confirmed that Hif1a regulates Twist2 expression (Figure 1i). Knockdown of Twist2 with specific siRNA partially restored the decrease in Ocn and Runx2 caused by Hif1a overexpression (Figure 1j). These data suggest that HIF-1α and HIF-2α have similar effects on osteoblast differentiation by regulating the TWIST2-RUNX2-OCN axis.

Figure 1. HIF-1α inhibits osteoblast differentiation via the TWIST2-RUNX2-OCN axis. (Lee S Y, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Will order again!

Achieved robust HIF1A expression in our hypoxia research with this adenovirus. Will order again!

Canada

07/01/2025

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER